An Oklahoma judge has ordered that Johnson & Johnson pay more than $572 million to abate the state's opioid crisis.
The bench verdict, announced by Cleveland County District Court Judge Thad Balkman on Monday, comes in the first trial against an opioid company. Oklahoma had asked for a $17.5 billion abatement plan over 30 years, alleging that Johnson & Johnson's Janssen Pharmaceuticals, as the sole defendant, created a public nuisance when it oversupplied opiate pharmaceuticals in the state, leading to massive deaths and addictions.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.